Almirall and ASLAN sign a global agreement on a novel treatment for Rheumatoid ArthritisGlobal Agreement • May 24th, 2012
Contract Type FiledMay 24th, 2012LAS186323 comes from Almirall’s successful history of drug-discovery and will be developed by Aslan to the end of Phase II for rheumatoid arthritis